Skip to content

Starting ART reduces TB risk for HIV-positive patients in South Africa

WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Implant and injectable hormonal contraception most effective methods for women living with HIV

Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health

Tony Mills at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy

Fatima Kakkar at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Gay youth PrEP study finds good retention and reasonable adherence

Sybil Hosek at IAS 2015 photo ©Marcus Rose/IAS

New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects

Dr José Gatell at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco

Christopher Pilcher at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com